Northern Trust (NASDAQ:NTRS – Get Free Report) and BR Biopharma (NASDAQ:BRBI – Get Free Report) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.
Valuation and Earnings
This table compares Northern Trust and BR Biopharma”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Northern Trust | $14.30 billion | 2.19 | $1.74 billion | $11.65 | 14.71 |
| BR Biopharma | $2.23 billion | 0.06 | $31.36 million | $0.08 | 142.26 |
Institutional and Insider Ownership
83.2% of Northern Trust shares are owned by institutional investors. 0.7% of Northern Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings for Northern Trust and BR Biopharma, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Northern Trust | 2 | 9 | 4 | 0 | 2.13 |
| BR Biopharma | 1 | 0 | 0 | 0 | 1.00 |
Northern Trust currently has a consensus target price of $180.93, suggesting a potential upside of 5.56%. Given Northern Trust’s stronger consensus rating and higher possible upside, analysts plainly believe Northern Trust is more favorable than BR Biopharma.
Dividends
Northern Trust pays an annual dividend of $3.52 per share and has a dividend yield of 2.1%. BR Biopharma pays an annual dividend of $0.42 per share and has a dividend yield of 3.7%. Northern Trust pays out 30.2% of its earnings in the form of a dividend. BR Biopharma pays out 525.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Profitability
This table compares Northern Trust and BR Biopharma’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Northern Trust | 14.76% | 16.91% | 1.18% |
| BR Biopharma | N/A | N/A | N/A |
Summary
Northern Trust beats BR Biopharma on 13 of the 15 factors compared between the two stocks.
About Northern Trust
Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; muti-asset and alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.
About BR Biopharma
BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.
Receive News & Ratings for Northern Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northern Trust and related companies with MarketBeat.com's FREE daily email newsletter.
